Blog Combination discount - a bureaucratic monster Implementation regulation of the combination discount according to section 130e SGB V named by the BMG more
Blog Few therapies, a lot of research Therapy options for paediatric dementia (neuronal ceroid lipofuscinosis) more
Blog The Medical Research Act Confidential reimbursement amounts in Germany only attractive for individual cases more
Blog The Medical Research Act Exemption from AMNOG pricing guardrails if relevant proportion of clinical trials are conducted in Germany more
Blog National strategy for gene and cell therapies (GCT) handed over Starting signal for a solution-orientated concept for Germany more
